Anti-PD-L1 checkpoint inhibitors: Decoding the mystery

July 24, 2019 | City of Hope

An study conducted by Michael Caligiuri, M.D., and Jianhua Yu, Ph.D., unveiled why anti-PD-L1 monoclonal antibodies (mAb) are still effective in fighting tumors that lack PD-L1 receptors on their cells.

Continue Reading

Researcher receives $1.35M Department of Defense grant for breast metastasis study

August 20, 2019 | Michael Easterling

Rahul Jandial, M.D., Ph.D., has received the “Breakthrough” award from the Department of Defense's Breast Cancer Research Program to support his study of leptomeningeal disease, which is characterized by the spreading of tumor cells to the lining of the brain and spinal cord.

Innovative approach using KITE-439 in targeting HPV-related malignancies

August 20, 2019 | City of Hope

HPV16-induced cancers, a strain that causes about 70% of all cervical cancers worldwide, are ideal candidates for targeted T cell therapy due to their nonself antigens.

Cancer screening guidance from City of Hope experts

August 16, 2019 | Samantha Bonar

August 16 is National Cancer Screening Day for breast, cervical and colorectal cancer. The day is an effort to increase awareness and education for breast, cervical and colorectal cancers.

City of Hope scientist receives $9.28M for CAR T trial for metastatic breast cancer

August 15, 2019 | Letisia Marquez

Saul Priceman, Ph.D., and his research team have received a $9.28 million award from the California Institute for Regenerative Medicine to support a CAR T cell phase 1 clinical trial for the treatment of women with HER2-positive breast cancer that has spread to the brain.

Researcher Awarded $3M Grant to Study Genomics of Breast Cancer in Latinas

August 14, 2019 | Jenny Peters

City of Hope researcher Susan Neuhausen, Ph.D., is studying genomic breast cancer risk among Latinas. The research is vital, as Latinas are underrepresented in studies of breast cancer and genetic risk assessment.

New ‘liquid biopsy’ blood test could improve breast cancer diagnostics

August 7, 2019 | Letisia Marquez

Developed by TGen and partners, the test could help avoid unnecessary surgeries and enable physicians to continuously monitor cancer. It works by measuring tiny particles of tumor DNA circulating in a patient's bloodstream.

Blood test could predict breast cancer relapse

July 8, 2019 | Zen Vuong

A special blood test may one day predict if a newly diagnosed breast cancer patient will likely relapse years later, a City of Hope study suggests.